Cargando…

Tuberculosis series 2019

Detalles Bibliográficos
Autores principales:	Silva, Denise Rossato, Migliori, Giovanni Battista, Mello, Fernanda Carvalho de Queiroz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Pneumologia e Tisiologia 2019
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6733734/ https://www.ncbi.nlm.nih.gov/pubmed/31038656 http://dx.doi.org/10.1590/1806-3713/e20190064

Ejemplares similares

Tuberculosis series 2020
por: Silva, Denise Rossato, et al.
Publicado: (2020)

Tuberculosis Series 2021
por: Silva, Denise Rossato, et al.
Publicado: (2021)

Tuberculosis series
por: Silva, Denise Rossato, et al.
Publicado: (2018)

Diagnosis and management of post-tuberculosis lung disease
por: Silva, Denise Rossato, et al.
Publicado: (2023)

Effects of COVID-19 on tuberculosis control: past, present, and future
por: Silva, Denise Rossato, et al.
Publicado: (2022)

Shortened tuberculosis treatment regimens: what is new?
por: Silva, Denise Rossato, et al.
Publicado: (2020)

Migration and medical screening for tuberculosis
por: Silva, Denise Rossato, et al.
Publicado: (2023)

Tuberculosis: where are we?
por: Mello, Fernanda Carvalho de Queiroz, et al.
Publicado: (2018)

Tuberculosis and COVID-19, the new cursed duet: what differs between Brazil and Europe?
por: Silva, Denise Rossato, et al.
Publicado: (2021)

In the time of strategies to end tuberculosis, prevention is better than treatment
por: Santos, Ana Paula, et al.
Publicado: (2020)

Global TB Network: working together to eliminate tuberculosis
por: Silva, Denise Rossato, et al.
Publicado: (2018)

The role of the Brazilian Tuberculosis Research Network in national and international efforts to eliminate tuberculosis
por: Kritski, Afranio, et al.
Publicado: (2018)

Eliminating tuberculosis in Latin America: making it the point
por: Duarte, Raquel, et al.
Publicado: (2018)

Latent tuberculosis and the use of immunomodulatory agents
por: Aguiar, Fábio Silva, et al.
Publicado: (2019)

“Post-tuberculosis financial disease”-we need to face it to eliminate tuberculosis
por: Santos, Ana Paula, et al.
Publicado: (2023)

International collaboration among medical societies is an effective way to boost Latin American production of articles on tuberculosis
por: Migliori, Giovanni Battista, et al.
Publicado: (2019)

Tuberculosis in the time of COVID-19: quality of life and digital innovation
por: Visca, Dina, et al.
Publicado: (2020)

Managing severe tuberculosis and its sequelae: from intensive care to surgery and rehabilitation
por: Tiberi, Simon, et al.
Publicado: (2019)

A new free-cost e-service supporting clinicians to manage their difficult-to-treat tuberculosis cases: The European Respiratory Society-World Health Organization tuberculosis Consilium
por: D’Ambrosio, Lia, et al.
Publicado: (2017)

Current use and acceptability of novel diagnostic tests for active tuberculosis: a worldwide survey
por: Amicosante, Massimo, et al.
Publicado: (2017)

Post-tuberculosis lung disease: a comparison of Brazilian, Italian, and Mexican cohorts
por: Silva, Denise Rossato, et al.
Publicado: (2022)

Tuberculosis and its future in the COVID-19 era: The Pulmonology series 2021
por: Migliori, G.B., et al.
Publicado: (2021)

Latent tuberculosis infection in patients with rheumatic diseases
por: Anton, Camila, et al.
Publicado: (2019)

Integrating Pharmacokinetics and Pharmacodynamics in Operational Research to End Tuberculosis
por: Alffenaar, Jan-Willem C, et al.
Publicado: (2020)

Management and outcomes of severe childhood tuberculosis in the pediatric intensive care setting: can we identify best practices?
por: Velizarova, Svetlana, et al.
Publicado: (2019)

Post-tuberculosis sequelae and their socioeconomic consequences: worth investigating
por: Sotgiu, Giovanni, et al.
Publicado: (2021)

New and repurposed drugs to treat multidrug- and extensively drug-resistant tuberculosis
por: Silva, Denise Rossato, et al.
Publicado: (2018)

Tuberculosis, COVID-19 and hospital admission: Consensus on pros and cons based on a review of the evidence
por: Migliori, Giovanni Battista, et al.
Publicado: (2021)

Risk factors for tuberculosis: diabetes, smoking, alcohol use, and the use of other drugs
por: Silva, Denise Rossato, et al.
Publicado: (2018)

Metrology for Agriculture and Forestry 2019
por: Chirico, Giovanni Battista, et al.
Publicado: (2020)

Breathing Back Better! A State of the Art on the Benefits of Functional Evaluation and Rehabilitation of Post-Tuberculosis and Post-COVID Lungs
por: Pontali, Emanuele, et al.
Publicado: (2022)

Regimens to treat multidrug-resistant tuberculosis: past, present and future perspectives
por: Pontali, Emanuele, et al.
Publicado: (2019)

Is there a rationale for pulmonary rehabilitation following successful chemotherapy for tuberculosis?
por: Muñoz-Torrico, Marcela, et al.
Publicado: (2016)

The definition of tuberculosis infection based on the spectrum of tuberculosis disease
por: Migliori, Giovanni Battista, et al.
Publicado: (2021)

Investigating the response to COVID-19 and understanding severe TB cases: The 2022 Pulmonology TB series
por: Migliori, G.B., et al.
Publicado: (2022)

Numbers needed to treat to prevent tuberculosis
por: Matteelli, Alberto, et al.
Publicado: (2015)

COVID-19 Related Hospital Re-organization and Trends in Tuberculosis Diagnosis and Admissions: Reflections From Portugal
por: Alves, Adelaide, et al.
Publicado: (2022)

New anti-tuberculosis drugs and regimens: 2015 update
por: D'Ambrosio, Lia, et al.
Publicado: (2015)

Prioritising children and adolescents in the tuberculosis response of the WHO European Region
por: Gröschel, Matthias I., et al.
Publicado: (2019)

Mandatory tuberculosis case notification in high tuberculosis-incidence countries: policy and practice
por: Uplekar, Mukund, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_gd1mtlgc3u17gpm1k54b9t5e2t